Jobs / United States / Glaxosmithkline LLC
Global Study Manager
Glaxosmithkline LLC · 🇺🇸 3 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Sr Manager - Oncology Commercial Analytics, Multiple Myeloma” (Data Scientists) in PA: $135k–$135k, median $135k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
This role within GCSD plays a pivotal part in driving the clinical operations of assigned studies, from Commit to Study Initiation (CSI) all the way through to study archiving. As a Global Study Manager (GSM) , you'll take ownership of crafting robust, accelerated delivery plans that aim for top-tier performance—ensuring timelines, quality standards, and ambitious targets are consistently achieved. Collaborating closely with the Global Study Lead (GSL) , you'll contribute to the seamless end-to-end delivery of the clinical study. As the GSM, you will lead the Operational Working Group (for in-house studies) and actively participate as a key member of the Central Study Team (CST) . This is a dynamic and impactful role designed for individuals driven to make a meaningful difference in clinical operations. This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following: • GSM will be the Working Group (WG) Lead for Clinical Operations with accountability for the operational delivery of clinical study/studies to time, quality, and budget, company standards and scientific requirements, supporting decision-making at pace and leading study team to achieve overall study deliverables • As Operational WG Lead, GSM is accountable for the following deliverables (to be adjusted accordingly for the STOM FSO model): - Study Initiation Meeting - Clinical Study Activity Plan - Study Delivery Plan - TMF Quality Strategy Document - DCT Set Up - Study Demographic and Diversity Plan - Vendors Oversight Plan - Results Dissemination Plan - Investigator/CRA Meeting Set Up & associated training - Expected Document List - Recruitment Tracking - Budget tracking eTMF filing and Vendor Set Up and Management - Patient Engagement Activities - CSDD KOM & template - Safety Management plan - Protocol Deviation Management Plan - eTMF & vendor set-up - Pharmacy Manual - Supports assessment and selection of FSO vendors • Accountable for holistic oversight of FSO vendors according to the FSO handbook • Responsible for assessment and selection of other study vendors under GCSD responsibility in consultation with GSL • Ensures compliance with ICH/GCP guidelines, all applicable laws and regulations, and GSK SOPs for assigned studies. understand study contribution to program/submission • Balances risk/benefit to make decisions based on clear understanding of impact on the study and project • Proactively and effectively identifies, oversees, and mitigates study risks • Ensures appropriate stakeholder communication, including study status, expectations, risks and issues • Accountable to operate within the study budget • Effectively leads empowered matrix teams • Implements innovative approaches to study delivery through external facing advances in technology and sciences and encourages others within matrix and line teams to seek innovative perspectives and develop solutions. • Responsible for operational input into protocol and informed consent form development, and other key study documents. • Leads and conducts investigator meetings and other study related meetings • Leads quality efforts to ensure protocol compliance and continual inspection readiness for assigned studies • Ensures data quality plans and end to end data cleaning is performed instream by the responsible line functions • Ensures Clinical Study Report is delivered on time and supports GSK’s adherence to local regulatory guidance • Oversees the activities of the countries participating in the study • Provides support and coaching (where appropriate) to the SM • Ambassadors in increasing utilization of AIML tools, driving automation of manual processes, finding efficiencies and more ef